We focused on Philadelphia Chromosome-positive (Ph+) B-ALL, a poor prognosis subtype driven by the BCR-ABL fusion oncogene that encodes a deregulated ABL tyrosine kinase. This evidence concerns the gene BCR and acute lymphoblastic leukemia.